Literature DB >> 14614060

Effects of sub-MIC concentrations of antibiotics on growth of and toxin production by Clostridium difficile.

Lisa J Drummond1, David G E Smith1, Ian R Poxton1.   

Abstract

Effects on growth and toxin A production of sub-MIC concentrations of six different antibiotics were investigated in three strains of Clostridium difficile: reference strain NCTC 11223, a fully sequenced strain (630) and a locally endemic isolate (strain 338a). The antibiotics chosen for investigation were the agents used to treat C. difficile-associated disease (CDAD), i.e. vancomycin and metronidazole, and four antibiotics that are commonly involved in precipitating CDAD (amoxycillin, clindamycin, cefoxitin and ceftriaxone). Strains were cultured in sublethal concentrations of antibiotics (1/2, 1/4 and 1/8 MIC) over 104 h and growth and toxin A production were measured three times a day. Effects varied between strain and antibiotic. The most common effect on growth of the strains was to increase the initial lag period by approximately 4 h, compared with antibiotic-free controls; however, strain NCTC 11223, which has high-level clindamycin resistance (> or = 512 microg ml(-1)), showed no lag whatsoever in comparison with the controls when grown in this antibiotic. The most common effect on production of toxin A was in the onset of toxin elaboration. Normally, toxins began to appear at low levels in the early stationary phase, before accumulating to high levels by the start of decline. In the presence of sub-MIC antibiotics, this onset appeared before that of the antibiotic-free controls. This effect was seen with metronidazole, amoxycillin and clindamycin, rarely with vancomycin and never with cefoxitin. These results suggest a very complex, strain-dependent relationship between the effects of growth and toxin production.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14614060     DOI: 10.1099/jmm.0.05387-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  21 in total

1.  Tigecycline suppresses toxin A and B production and sporulation in Clostridium difficile.

Authors:  Michael John Aldape; Dustin Delaney Heeney; Amy Evelyn Bryant; Dennis Leroy Stevens
Journal:  J Antimicrob Chemother       Date:  2014-08-23       Impact factor: 5.790

Review 2.  Vaccines against Clostridium difficile.

Authors:  Rosanna Leuzzi; Roberto Adamo; Maria Scarselli
Journal:  Hum Vaccin Immunother       Date:  2014-03-17       Impact factor: 3.452

3.  Inhibition of Protein Secretion in Escherichia coli and Sub-MIC Effects of Arylomycin Antibiotics.

Authors:  Shawn I Walsh; David S Peters; Peter A Smith; Arryn Craney; Melissa M Dix; Benjamin F Cravatt; Floyd E Romesberg
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

4.  Alterations of growth rate and gene expression levels of UPEC by antibiotics at sub-MIC.

Authors:  Defne Gümüş; Fatma Kalaycı-Yüksek; Emre Yörük; Gülşen Uz; Eşref Çelik; Cansu Arslan; Elif Merve Aydın; Cem Canlı; Mine Anğ-Küçüker
Journal:  Folia Microbiol (Praha)       Date:  2018-01-11       Impact factor: 2.099

Review 5.  Models for the study of Clostridium difficile infection.

Authors:  Emma L Best; Jane Freeman; Mark H Wilcox
Journal:  Gut Microbes       Date:  2012-03-01

Review 6.  Lag Phase Is a Dynamic, Organized, Adaptive, and Evolvable Period That Prepares Bacteria for Cell Division.

Authors:  Robert L Bertrand
Journal:  J Bacteriol       Date:  2019-03-13       Impact factor: 3.490

7.  Effects of ciprofloxacin on the expression and production of exotoxins by Clostridium difficile.

Authors:  Michael John Aldape; Aaron Eugene Packham; Drew William Nute; Amy Evelyn Bryant; Dennis Leroy Stevens
Journal:  J Med Microbiol       Date:  2013-02-21       Impact factor: 2.472

8.  Effects of subinhibitory concentrations of antibiotics on colonization factor expression by moxifloxacin-susceptible and moxifloxacin-resistant Clostridium difficile strains.

Authors:  Cécile Denève; Sylvie Bouttier; Bruno Dupuy; Frédéric Barbut; Anne Collignon; Claire Janoir
Journal:  Antimicrob Agents Chemother       Date:  2009-10-05       Impact factor: 5.191

9.  Tolevamer, an anionic polymer, neutralizes toxins produced by the BI/027 strains of Clostridium difficile.

Authors:  Paul L Hinkson; Carol Dinardo; Daniel DeCiero; Jeffrey D Klinger; Robert H Barker
Journal:  Antimicrob Agents Chemother       Date:  2008-04-07       Impact factor: 5.191

10.  Benzyl and benzoyl benzoic acid inhibitors of bacterial RNA polymerase-sigma factor interaction.

Authors:  Jiqing Ye; Adrian Jun Chu; Lin Lin; Shu Ting Chan; Rachel Harper; Min Xiao; Irina Artsimovitch; Zhong Zuo; Cong Ma; Xiao Yang
Journal:  Eur J Med Chem       Date:  2020-08-18       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.